Has John Kelly received payments from drug or device companies?

Yes. Drug and device makers reported $17,914 in general payments to John Kelly across 181 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Kelly did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Kelly come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Kelly

Occupational Health · Visalia, CANPI 1336696780

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (53.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 74.3% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $5,026 and has fallen 96.0% since, to $200 in 2025. Among occupational health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,914in general payments, 2019–2025

Across 181 payments — averaging $98.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$13K
Amgen$3K
Merck$405
Johnson & Johnson$223
Bayer$194
Boehringer Ingelheim$193
plus $647 from 14 others

What the payments were for

Food & beverage$4,57226%
Education$3,74221%
Other$9,60054%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	8	$13,307
Amgen	107	$2,946
Merck	21	$405
Johnson & Johnson	6	$223
Bayer	7	$194
Boehringer Ingelheim	9	$193
Alnylam Pharmaceuticals Inc.	2	$152
Treace Medical Concepts, Inc.	1	$129
Lilly USA, LLC	4	$64
Pfizer	3	$53
Baxter Healthcare	2	$44
Amarin Pharma, Inc.	2	$36
Smith+Nephew	2	$32
Bardy Diagnostics, Inc.	1	$30
Abiomed	1	$24
Novo Nordisk	1	$21
Actelion Pharmaceuticals US, Inc.	1	$19
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$17
Lexicon Pharmaceuticals, Inc.	1	$15
Tactile Systems Technology Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,914 in reported general payments places this provider in the 95th percentile of 33 occupational health providers in California.

See all occupational health providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Repatha SureclickEvolocumab	12	$12,555
EliquisApixaban	15	$10,782
VascepaIcosapent Ethyl	15	$5,687
Gabapentin	29	$593
Ezetimibe	25	$412
Atorvastatin Calcium	26	$150
Metoprolol Succinate	14	$130
Furosemide	25	$115
Spironolactone	11	$76
Carvedilol	20	$72
Ondansetron Hcl	14	$44
Prednisone	17	$24

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$53	$10,78215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 33 occupational health providers in California.

Other occupational health in Visalia

Teresa SimasVisalia$2K
Curtis ChowRedding$3K
Cynthia McNaughtonMountain View$2K
Danny SongSan Diego$1K
Barbara RegisSan Diego$1K
Leilani WagnerModesto$1K
Marlene MuirSan Ramon$781
Ekaterina CarmenattyStanford$397
Nancy SeilerSan Luis Obispo$268
Evangelina RamirezLos Angeles$223

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →